Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer
about
Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damageEmerging roles of Nrf2 signal in non-small cell lung cancerThe complexity of the Nrf2 pathway: beyond the antioxidant responseThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersPERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitisNrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1)Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial CellsCullin 3 as a novel target in diverse pathologiesErythroblast transformation-specific 2 correlates with vascular smooth muscle cell apoptosis in rat heterotopic heart transplantation modelInvolvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres.PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisRole of the Nrf2 signaling system in health and disease.Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.Overexpression of MYCN promotes proliferation of non-small cell lung cancer.Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.Cycloartenyl Ferulate Inhibits Paraquat-Induced Apoptosis in HK-2 Cells With the Involvement of ABCC1.Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.Impacts of somatic mutations on gene expression: an association perspective.Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia.Utility of checklist to describe experimental methods for investigating molecular biomarkers.Mifepristone-inducible recombinant adenovirus attenuates paraquat-induced lung injury in rats.Cardiac Aging - Benefits of Exercise, Nrf2 Activation and Antioxidant Signaling.NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.Selective ATP-Binding Cassette Subfamily C Gene Expression and Proinflammatory Mediators Released by BEAS-2B after PM2.5, Budesonide, and Cotreated Exposures.Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status.Keap1-Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics.MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity.
P2860
Q26995211-9E3ED514-49C3-4FBD-9516-436589310359Q28078928-5D4E19F2-7E3C-42F6-9D89-155615C0DA9CQ28389296-D6A322BD-D1F1-4470-8053-F9849A15EF63Q28395641-F571C785-DF56-4A10-A36F-5A7695A8075BQ33667531-6D156934-662A-4A95-956C-4473192613A5Q35215772-65CB40FF-AED9-4933-ACBF-5B1E6755067EQ36428498-11F591E5-4FD4-4836-804D-BA41AE1CB3DEQ36468929-AB02C7BB-CF77-4BEC-89FB-5212042348AEQ36561564-875E0B43-24B3-4667-9E30-F76E9895F609Q36876161-25312945-3325-473D-AF07-A01606FB9763Q37133559-079DDB94-5792-41E4-A3A9-9F3D5B20319CQ37208630-661631B4-055E-48A3-B293-16C020022749Q37235244-0AEAF1D5-80FE-4147-B19E-6B965D9A94C7Q37577924-A771C94F-1CC5-42E7-B0A7-379E77701530Q37641588-41B071BF-BC5F-42DA-BE0D-BA23C0EA04DFQ37676777-ED10E464-A411-4131-BA05-9CE6D37B885DQ38216015-B08789F9-F784-4548-B825-AD306EE9EF7CQ38237494-1250C272-4284-4AF1-BBD9-DFB10BDC74BCQ38700191-CBEE96D1-78A5-4203-920C-25D27FB19AB8Q38714809-0456E5FC-8951-4D0A-BA16-48CD7A8D8546Q38719990-55049270-5ED7-446D-8B1D-D6B7890A288CQ38736893-ECB472D8-1EC3-40C8-A01E-7B362CB613F3Q38763444-6BDEF3D0-371E-4E10-B949-986F02EAE556Q38808345-291110D5-5A0A-4AAD-8E41-64FCF4D2D09EQ38827103-BDE7395A-3A9A-4932-A71D-2F3133F9D9C6Q38836232-0E5D98C7-DB73-42D6-899A-94EDE36B7C8DQ38868671-C3B1D364-8499-4E01-82FA-62F2814F1E36Q38874064-9CABECB6-BBC2-4E15-B198-F08E56308C11Q38906160-F4841BDE-4B91-4FE8-8726-8E5E9E0F539AQ38914271-7ED78062-A8CB-4845-A655-89B30BF15CAEQ39224142-326068DE-CFB8-4DCD-817E-D912FE9D5BB7Q40463386-23E59290-139E-4440-B804-61F5C59802DCQ42219700-CB79C625-EDA5-46AD-9EFC-65B281E6C3D3Q46288550-914AC077-9DB3-41F9-BCA0-F1B1120A0A45Q47111415-14E15521-422F-4ED7-8FFE-444F9499AE3BQ47813843-6DA6561B-87F6-4DF1-8646-E78C422388B3Q49303366-7C0FFB0A-E187-49A5-A33D-C64538E444E2Q50921781-6B09AC80-3971-4698-858A-66C65EFDCEACQ50926633-9FC0595D-753C-4E53-88DC-4240D41ED74DQ51315484-3B0EBEF2-1D2F-45BF-8629-90DB6E30DB50
P2860
Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@ast
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@en
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@nl
type
label
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@ast
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@en
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@nl
prefLabel
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@ast
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@en
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@nl
P2093
P2860
P3181
P1433
P1476
Nrf2 pathway regulates multidr ...... in 1 in small cell lung cancer
@en
P2093
Donna D Zhang
Guoguo Shang
Nong Zhang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0063404
P407
P577
2013-01-01T00:00:00Z